SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Qualcomm Moderated Thread - please read rules before posting
QCOM 159.42-1.2%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Bechhoefer who wrote (67904)8/18/2007 2:58:48 PM
From: rkral  Read Replies (1) of 197273
 
"Does anyone suspect (besides me) that this continuation patent may be invalid, in lieu of the Supreme Court decision in the KSR-Teleflex case? Continuation patents as a group may now be deemed obvious. "

Not me. Besides speculation, what is your basis for those statements?

"This is the very issue that worries drug firms, who have enthusiastically used minor variations in drugs going off patent protection to prolong their exclusivity."

Could we please limit the discussion to utility patents, e.g., in telecommunications and electronics?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext